The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
Market view
bexagliflozin · Tablet
6 marketed package NDCs · 2 active manufacturers
Most dispensed: 20 mg · Tablet · #30 tablets/bottle · 25 kg/25kg · Powder · #5 kg/drum · 20 mg · Tablet · #90 tablets/bottle
Same drug class
Other molecules FDA puts in Sodium-Glucose Cotransporter 2 Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- dapagliflozin and saxagliptin· 1 maker
- empagliflozin and linagliptin· 1 maker
- empagliflozin, linagliptin, metformin hydrochloride· 1 maker
- empagliflozin, metformin hydrochloride· 1 maker
- canagliflozin and metformin hydrochloride· 2 makers
- empagliflozin and metformin hydrochloride· 2 makers
- sotagliflozin· 2 makers
- dapagliflozin and metformin hydrochloride· 9 makers
- canagliflozin· 12 makers
- empagliflozin· 31 makers
- dapagliflozin· 40 makers
Common questions
- Is Bexagliflozin in shortage right now?
- No. FDA does not currently list Bexagliflozin in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Bexagliflozin?
- 3 companies have marketed Bexagliflozin in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.